author-photo

Mary OBrien

The Royal Marsden NHS Foundation Trust

12

Papers

56

Citations

Citation Trend

Filter By

Papers (8) Sort By

Journal Conference Others

Immune Checkpoint Inhibitor and Radiotherapy-Related Pneumonitis: An Informatics Approach to Determine Real-World Incidence, Severity, Management, and Resource Implications.

2021 Frontiers of Medicine in China
Show All
- Source
- Cite
- Save
Citations (0)
HER3 expression and MEK activation in non-small-cell lung carcinoma

2021 Lung cancer management
Show All
- Source
- Cite
- Save
Citations (0)
Combined, patient-level, analysis of two randomised trials evaluating the addition of denosumab to standard first-line chemotherapy in advanced NSCLC - The ETOP/EORTC SPLENDOUR and AMGEN-249 trials.

2021 Lung Cancer
Show All
- Source
- Cite
- Save
Citations (0)
Five-Year Outcomes With Pembrolizumab Versus Chemotherapy for Metastatic Non-Small-Cell Lung Cancer With PD-L1 Tumor Proportion Score ≥ 50.

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (36)
Adaptive immunity to SARS-CoV-2 in cancer patients: The CAPTURE study

2020 medRxiv
Show All
- Source
- Cite
- Save
Citations (4)
Radiological evaluation of malignant pleural mesothelioma - defining distant metastatic disease.

2020 BMC Cancer
Show All
- Source
- Cite
- Save
Citations (1)
P3.02b-046 Afatinib Benefits Patients with Confirmed/Suspected EGFR Mutant NSCLC, Unsuitable for Chemotherapy (TIMELY Phase II Trial)

2017 Journal of Thoracic Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Poster SessionP3.02b-046 Afatinib Benefits Patients with Confirmed/Suspected EGFR Mutant NSCLC, Unsuitable for Chemotherapy (TIMELY Phase II Trial): Topic: EGFR Clinical

2017 Journal of Thoracic Oncology
Show All
- Source
- Cite
- Save
Citations (0)